Skip to content
Screener

Ardent Health Partners ARDT Cash & Equivalents

Cash & Equivalents at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
$2.17B-17.3%
HCA Healthcare logo
HCA HealthcareHCA
$1.01B+7.9%
Community Health Systems logo
Community Health SystemsCYH
$149M-67.3%
Surgery Partners, Inc. logo
Surgery Partners, Inc.SGRY
$182.3M-20.5%
Universal Health Services logo
Universal Health ServicesUHS
$138.8M+0.9%
National Healthcare logo
National HealthcareNHC
$39.21M-64.7%

Other financials

Income statement

See full
Revenue$1.6B+7.0%
Gross profit$1.6B+6.7%
Net income$39.9M-3.7%
EPS (diluted)$0.28-3.4%

Balance sheet

See full
Total debt$1.2B+1.7%
Total equity$1.3B+13.8%
Total assets$5.3B+7.0%

Cash flow

See full
Operating cash flow-$60.2M-143%
CapEx$28.1M+22.6%
Free cash flow-$88.3M-85.2%

Valuation

See full
Market cap$1.66B+2.7%
Enterprise value$2.22B-0.5%
P/E12.4×+6.0×
P/S0.3×0.0×

Profitability

See full
Gross margin97.5%-0.1pp
Net margin2.1%-1.6pp
FCF margin3.4%+1.4pp

Returns & leverage

See full
Return on equity10.7%-9.0pp
Debt / equity0.9×-0.1×
Current ratio2.1×0.0×

Where this comes from

Reported directly by Ardent Health Partners in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The source filing: Ardent Health Partners’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 4:19 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-031299
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Distributions to noncontrolling interests(21,314)(19,239)
Other(1,014)(1,061)
Net cash used in financing activities(11,786)(13,832)
Net decrease in cash and cash equivalents(99,909)(61,741)
Cash and cash equivalents at beginning of period709,601556,785
Cash and cash equivalents at end of period$609,692$495,044
Supplemental Cash Flow Information:
Non-cash purchases of property and equipment$936$6,662

Item 6. [Exhibits](#ia6f10f802308479b8bc8bad2facfb7e9_217) [38](#ia6f10f802308479b8bc8bad2facfb7e9_217)

FAQ

What is Ardent Health Partners's cash & equivalents?
Ardent Health Partners (ARDT) reported cash & equivalents of $609.69M in Q1 2026.
How has Ardent Health Partners's cash & equivalents changed year-over-year?
Ardent Health Partners's cash & equivalents increased by 23.2% year-over-year, from $495.04M to $609.69M.
What is the long-term trend for Ardent Health Partners's cash & equivalents?
Over 3 years (2022 to 2025), Ardent Health Partners's cash & equivalents has grown at a 15.9% compound annual growth rate (CAGR), from $456.12M to $709.6M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Ask your AI about Ardent Health Partners's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude